Metraipolis › archive › dc_08f6fa3490d4
Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma — Europe PMC PMID:42957845
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42957845
- DOI
- 10.1007/s00277-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T15:24:24.677Z
- SHA-256 of the archived text
c3b14328a5f2195413b8c0efc694c3c7c7baa5af97c5961d28d3789b6b4d94af- Stable URL of this page
https://metraipolis.com/documento/dc_08f6fa3490d4
How to cite
Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma — Europe PMC PMID:42957845 — Europe PMC (en), https://europepmc.org/article/MED/42957845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_08f6fa3490d4 (Metraipolis archive dc_08f6fa3490d4, sha256 c3b14328a5f2195413b8c0efc694c3c7c7baa5af97c5961d28d3789b6b4d94af)
BibTeX
@misc{dc08f6fa3490d4,
title = {Post-transplant BRAF/MEK inhibitor maintenance sustains complete remission in BRAF V600E-mutant histiocytic sarcoma — Europe PMC PMID:42957845},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42957845},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_08f6fa3490d4; sha256 c3b14328a5f2195413b8c0efc694c3c7c7baa5af97c5961d28d3789b6b4d94af},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42957845. Agents can read the archived copy with the MCP tool read_document.